Data / Form D filings / TORL Biotherapeutics LLC
TORL Biotherapeutics LLC: Form D filing
TORL Biotherapeutics LLC, a pharmaceuticals company in Culver City, CA, filed a Form D with the SEC in 2024. The latest, on April 17, 2024, reports $158.3 million sold of a $158.3 million offering to 52 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6100 Bristol Parkway, Culver City, CA, 90230
- Phone
- (424) 652-9370
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1797180
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 17, 2024 | New notice | $158,300,000 | $158,300,000 | 52 | Apr 4, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark Alles | Executive Officer, Director | |
| Mark Attanasio | Director | |
| David Licata | Executive Officer, Director | |
| Neil O'Brien | Director | |
| Amit Sinha | Director | |
| Lynn Seely | Director | |
| Dennis Slamon | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Apr 15, 2024 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what TORL Biotherapeutics LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.